Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural Hematoma

NCT05713630 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT05713630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05713630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural Hematoma
Lead sponsor
Unity Health Toronto
Phase
Phase 3
Overall status
Recruiting
Start date
May 20, 2026
Completion date
December 31, 2030
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subdural hematoma